Gyre Therapeutics, Inc 10-Q for FY2025 Q2
Gyre Therapeutics, Inc. (GYRE)
10-Q
2025-08-11
For: 2025-06-30
View Original
Added on
April 08, 2026
About this 10-Q
Gyre Therapeutics, Inc filed this 10-Q on August 11, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).
Headline figures
Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $26.77M
- up 6.1% from $25.23M a year earlier
- Net income
- $1.58M
- down 65.3% from net income of $4.54M a year earlier
- Diluted EPS
- $0.00
- compared with $0.01 a year earlier